Dear Reader,
We have identified several healthtech stocks which are expected to go “Ex-Dividend” starting November 23rd, 2022.
If you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment.
Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
So please keep this in mind.
Below is our latest Dividend Report:
Bruker
Symbol: BRKR
Recent BRKR Stock Price: $66.25
Average Analyst Price Target: $74.50 (12.45%)
BRKR Market Cap: $10.12B
Expected Ex-Dividend Date for BRKR stock: Nov 30 2022
Expected Payment Date for BRKR stock: Dec 16 2022
Expected Dividend & Yield for BRKR stock: 0.28%
Recent Analyst Action: Max Masucci, analyst at Cowen & Co., reiterates coverage on Bruker (BRKR) stock in the Healthcare sector with a Hold rating and a price target of $ 75 (2 weeks ago).
TipRanks.com also reports that Bruker stock currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $74.50 . The target pricing ranges from a high forecast of $75.00 down to a low forecast of $73.00. Bruker (BRKR)’s last closing stock price was $66.25 which would put the average price target at 12.45% upside.Here are 3rd party ratings for BRKR stock:
- TipRanks.com: Strong Buy
- TradingView.com: n/a (possibly response change)
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Weak buy
- Zacks.com: Hold, Bottom 33% (167 out of 251)
--------------------------------------------------------------------------
McKesson
Symbol: MCK
Recent MCK Stock Price: $380.34
Average Analyst Price Target: $423.30 (11.30%)
MCK Market Cap: $54.36B
Expected Ex-Dividend Date for MCK stock: Nov 30 2022
Expected Payment Date for MCK stock: Jan 03 2023
Expected Dividend & Yield for MCK stock: 0.51%
Recent Analyst Action: A.J. Rice, analyst at Credit Suisse, reiterates coverage on McKesson (MCK) stock in the Healthcare sector with a Buy rating and a price target of $ 419 (6 days ago).
TipRanks.com also reports that McKesson stock currently has 10 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $423.30 . The target pricing ranges from a high forecast of $450.00 down to a low forecast of $376.00. McKesson (MCK)’s last closing stock price was $380.34 which would put the average price target at 11.30% upside.Here are 3rd party ratings for MCK stock:
- TipRanks.com: Strong Buy
- TradingView.com: n/a (possibly response change)
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong buy
- Zacks.com: Buy, Bottom 28% (180 out of 251)
--------------------------------------------------------------------------
Premier
Symbol: PINC
Recent PINC Stock Price: $32.88
Average Analyst Price Target: $37.60 (14.36%)
PINC Market Cap: $3.95B
Expected Ex-Dividend Date for PINC stock: Nov 30 2022
Expected Payment Date for PINC stock: Dec 15 2022
Expected Dividend & Yield for PINC stock: 2.45%
Recent Analyst Action: Anne Samuel, analyst at J.P. Morgan, reiterates coverage on Premier (PINC) stock in the Healthcare sector with a Hold rating and a price target of $ 30 (1 week ago).
TipRanks.com also reports that Premier stock currently has 5 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $37.60 . The target pricing ranges from a high forecast of $46.00 down to a low forecast of $30.00. Premier (PINC)’s last closing stock price was $32.88 which would put the average price target at 14.36% upside.Here are 3rd party ratings for PINC stock:
- TipRanks.com: Moderate Buy
- TradingView.com: n/a (possibly response change)
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Hold, Bottom 49% (127 out of 251)
--------------------------------------------------------------------------
Universal Health
Symbol: UHS
Recent UHS Stock Price: $129.13
Average Analyst Price Target: $126.38 (-2.13%)
UHS Market Cap: $8.52B
Expected Ex-Dividend Date for UHS stock: Nov 30 2022
Expected Payment Date for UHS stock: Dec 15 2022
Expected Dividend & Yield for UHS stock: 0.62%
Recent Analyst Action: Jonathan Yong, analyst at Credit Suisse, reiterates coverage on Universal Health (UHS) stock in the Healthcare sector with a Buy rating and a price target of $ 157 (4 days ago).
TipRanks.com also reports that Universal Health stock currently has 8 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $126.38 . The target pricing ranges from a high forecast of $157.00 down to a low forecast of $113.00. Universal Health (UHS)’s last closing stock price was $129.13 which would put the average price target at -2.13% upside.Here are 3rd party ratings for UHS stock:
- TipRanks.com: Hold
- TradingView.com: n/a (possibly response change)
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: buy
- Zacks.com: Hold, Top 38% (96 out of 251)
--------------------------------------------------------------------------
And there you have it...
Keep in mind, if you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment.
Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
If you have questions about specific dividends, you should consult with your financial advisor or visit Investor.gov for more information.
Sincerely,
The Editor, HealthTechMovers.com
HealthTechMovers.com (HTM) is built for investors who are interested in healthcare stocks, health insurance stocks, healthcare technology stocks, biotechnology stocks, pharmaceutical stocks, healthcare service provider stocks, life science stocks and more. HTM aggregates market data from top tier financial content providers like Barchart.com, Tipranks.com, TradingView.com, Yahoo! Finance, and Zacks.com. The research and editorial team behind HTM consolidates this aggregated data into easily consumable reports used to produce articles, newsletters, and web content. The reports produced by HTM contain timely information stock analysis, stock price targets, earnings announcements, insider trades, dividends, and top moving stocks.
